BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9045328)

  • 1. Paclitaxel in head and neck and other cancers: future prospects.
    Aisner J; Cortés-Funes H
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-113-S2-115. PubMed ID: 9045328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel (Taxol) for the treatment of head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):49-52. PubMed ID: 7939763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined modalities in the treatment of head and neck cancers.
    Aisner J; Hiponia D; Conley B; Jacobs M; Gray W; Belani CP
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):28-34. PubMed ID: 7541154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
    Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: phase I studies.
    Rosenthal DI; Okani O; Truelson JM; Fathallah-Shaykh H; Vuitch FM; Gazdar AF; Griener J; Landay M; Mendelsohn D; Tourville J; Hamilton L; Orr KY; McWhorter J; Carbone DP
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-81-S2-84. PubMed ID: 9045344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of paclitaxel in the treatment of head and neck cancer.
    Vokes EE; Haraf DJ; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum RR
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):8-12. PubMed ID: 7481866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel: current developmental approaches of the National Cancer Institute.
    Arbuck SG
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):55-63. PubMed ID: 8643972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel, carboplatin, and long-term continuous 5-fluorouracil infusion in the treatment of upper aerodigestive malignancies: preliminary results of phase II trial.
    Hainsworth JD; Meluch AA; Greco FA
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-38-S19-42. PubMed ID: 9427264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck.
    Conley B; Jacobs M; Suntharalingam M; Zacharski D; Ord RA; Gray W; Aisner J
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-78-S2-80. PubMed ID: 9045343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel in simultaneous radiochemotherapy of head and neck cancer: preclinical and clinical results.
    Hoffmann W; Rodemann HP; Belka C; Budach W; Schmidberger H; Bochtler H; Heinrich V; Bamberg M
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-72-S2-77. PubMed ID: 9045342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer.
    Vokes EE; Stupp R; Haraf D; Moran W; Malone D; Wenig B; Sweeney P; Weichselbaum RR
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):47-52. PubMed ID: 7597433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
    Haraf DJ; Stenson K; List M; Witt ME; Weichselbaum RR; Vokes EE
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-68-S2-71. PubMed ID: 9045341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-based chemotherapy for recurrent and/or metastatic head and neck squamous cell carcinoma: current and future directions.
    Shin DM; Lippman SM
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):100-5. PubMed ID: 10190789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxol plus radiation for head and neck cancer.
    Rosenthal DI; Carbone DP
    J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
    Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
    Bunn PA
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
    Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel pharmacology and other tumor types.
    Rowinsky EK
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel in the treatment of esophageal cancer.
    Weiner LM
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):106-8. PubMed ID: 10190790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.